FILTER
Prikaži samo sadržaje koji zadovoljavaju:
objavljeni u periodu:
na jeziku:
hrvatski engleski
sadrže pojam:

SK, biatlon: Trostruka pobjeda Francuza na sprintu u Oberhofu

AC Milan želi Rashforda

Maduro položio prisegu za treći šestogodišnji mandat, zemlja dobila nove sankcije

SAD uveo sankcije Gazprom Neftu i srpskom NIS-u, traže se rješenja za Janaf

Najava događaja - Hrvatska - za subotu, 11. siječnja

Nove američke sankcije Rusiji podigle cijene nafte prema 79 dolara

Gospodarstvo - ukratko do 17,30 sati

Tjedna najava događaja - Hrvatska - od 11. do 17. siječnja

ZSE: Crobexi na kraju tjedna s novim rekordnim razinama

Obuljen Koržinek: Odlaskom Olge Ramljak hrvatski medijski prostor izgubio doajena

Pliva finishes sale of Sanctura drug

Izvor: HINA
Autor: ;mses;
ZAGREB, July 4 (Hina) - The leading Croatian pharmaceutical companyPliva has wrapped up the sale of its Sanctura drug to the EspritPharma Holding Company, reads a press release which Pliva sent to theZagreb Stock Exchange.
ZAGREB, July 4 (Hina) - The leading Croatian pharmaceutical company Pliva has wrapped up the sale of its Sanctura drug to the Esprit Pharma Holding Company, reads a press release which Pliva sent to the Zagreb Stock Exchange.

Upon the completion of the transaction, Pliva received 45 million US dollars from Esprit, and is entitled to additional sums up to 95 million dollars which are linked to the accomplishment of four goals in the sale.

This transaction will lead to the decrease of Pliva's book value by 93 million dollars in the second quarter of this year.

(Hina) ms

An unhandled error has occurred. Reload 🗙